• Explore /
  • Poster
  • / Pathologic outcomes at cytoreductive nephrectomy (CN) following immunotherapy (IO) for patients with advanced renal cell carcinoma (RCC).

Pathologic outcomes at cytoreductive nephrectomy (CN) following immunotherapy (IO) for patients with advanced renal cell carcinoma (RCC).

Abstract Poster

Authors

Justine Panian

Justine Panian

University of California San Diego, Moores Cancer Center, La Jolla, CA

Justine Panian , Ava Saidian , Kevin Hakimi , Archana Ajmera , Pedro C. Barata , Stephanie A. Berg , Steven Lee Chang , Toni K. Choueiri , Hannah Elizabeth Dzimitrowicz , Hamid Emamekhoo , Evan Gross , Deepak Kilari , Elaine Tat Lam , Isabel Lashgari , Sarah P. Psutka , Bicky Thapa , Nicole Weise , Tian Zhang , Ithaar Derweesh , Rana R. McKay

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 334)

DOI

10.1200/JCO.2022.40.6_suppl.334

Abstract #

334

Poster Bd #

F7

Abstract Disclosures

Similar Posters

First Author: Elaine Chang

First Author: Lucia Carril-Ajuria

First Author: Nizar M. Tannir

First Author: Hamid Emamekhoo